Andrew Steinmetz works in retail and has an outgoing personality. “I really like the pace of working in the store,” says Andrew Steinmetz, 23, who is a manager at a business supply store in Philadelphia. Andrew’s upbeat and positive attitude is evident a...
Read MoreMeet Michelle Savage, Fox Chase's New Genetic Counselor
Michelle Savage was born and raised in Bucks County, PA, and grew up familiar with Fox Chase Cancer Center. She completed her undergraduate studies at Boston University, earning her BA in biology, with a concentration in cell biology, molecular biology and ...
Read MoreMeet Michelle Savage, Fox Chase's New Genetic Counselor
Why is it Important for Breast Cancer Patients to Understand Their Disease?
A new diagnosis of breast cancer brings with it a set of important decisions about type of treatment and long term prognosis that every breast cancer patient and her providers must address. Cancer Characteristics These decisions are largely based on t...
Read MoreWhy is it Important for Breast Cancer Patients to Understand Their Disease?
A New Procedure Called HIPEC Offers New Treatment Options for Cancer Patients
The acronym HIPEC stands for hyperthermic intraperitoneal chemotherapy. This procedure is a novel method of delivering chemotherapy in the operating room during surgery for the treatment of advanced cancers that have spread to the lining o...
Read MoreA New Procedure Called HIPEC Offers New Treatment Options for Cancer Patients
Reaching Young Adults: Development of an Internet Intervention for Skin Cancer Prevention
Several studies have shown that young adults 18 to 25 years old commonly expose themselves to ultraviolet (UV) radiation, either from the sun or indoor tanning, without using sunscreen or other skin protection.This exposure is a known risk factor for skin c...
Read MoreReaching Young Adults: Development of an Internet Intervention for Skin Cancer Prevention
Exciting News in the Fight Against Lung Cancer
A news story in USA Today’s January 13, 2015 edition reported that a new cancer drug, Opdivo, is working so successfully that maker Bristol-Myers Squibb announced this week that it is ending a trial in lung cancer two years ahead of schedule. “We partici...
Read MoreExciting News in the Fight Against Lung Cancer
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this